Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden

Aurélie AG Gabriel, View ORCID ProfileJoshua R Atkins, View ORCID ProfileRicardo CC Penha, View ORCID ProfileKarl Smith-Byrne, Valerie Gaborieau, Catherine Voegele, View ORCID ProfileBehnoush Abedi-Ardekani, Maja Milojevic, Robert Olaso, Vincent Meyer, Anne Boland, Jean François Deleuze, David Zaridze, Anush Mukeriya, Beata Swiatkowska, Vladimir Janout, Miriam Schejbalová, Dana Mates, Jelena Stojšić, Miodrag Ognjanovic, John S Witte, View ORCID ProfileSara R Rashkin, View ORCID ProfileLinda Kachuri, Rayjean J Hung, View ORCID ProfileSiddhartha Kar, View ORCID ProfilePaul Brennan, Anne-Sophie Sertier, Anthony Ferrari, Alain Viari, View ORCID ProfileMattias Johansson, View ORCID ProfileChristopher I Amos, View ORCID ProfileMatthieu Foll, View ORCID ProfileJames D McKay
doi: https://doi.org/10.1101/2021.04.26.21254132
Aurélie AG Gabriel
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua R Atkins
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua R Atkins
Ricardo CC Penha
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo CC Penha
Karl Smith-Byrne
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karl Smith-Byrne
Valerie Gaborieau
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Voegele
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Behnoush Abedi-Ardekani
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Behnoush Abedi-Ardekani
Maja Milojevic
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Olaso
2Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Meyer
2Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Boland
2Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean François Deleuze
2Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Zaridze
3Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anush Mukeriya
3Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beata Swiatkowska
4Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Janout
5Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Schejbalová
6Charles University 1st Faculty of Medicine, Prague Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Mates
7National Institute of Public Health, Bucharest, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jelena Stojšić
8Department of Thoracic Pathology, Service of Pathology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miodrag Ognjanovic
9International Organisation for Cancer Prevention and Research, Belgrade, Serbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S Witte
10Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara R Rashkin
10Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA
11Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara R Rashkin
Linda Kachuri
10Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Linda Kachuri
Rayjean J Hung
12Lunenfeld Tanenbaum Research Institute, Sinai Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siddhartha Kar
13MRC Integrative Epidemiology Unit, University of Bristol, UK
14Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Siddhartha Kar
Paul Brennan
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Brennan
Anne-Sophie Sertier
15Synergie Lyon Cancer, Plateforme de bioinformatique ‘Gilles Thomas’ Centre Léon Bérard, 28 promenade Lea et Napoleon Bullukian, 69008 Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Ferrari
15Synergie Lyon Cancer, Plateforme de bioinformatique ‘Gilles Thomas’ Centre Léon Bérard, 28 promenade Lea et Napoleon Bullukian, 69008 Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Viari
15Synergie Lyon Cancer, Plateforme de bioinformatique ‘Gilles Thomas’ Centre Léon Bérard, 28 promenade Lea et Napoleon Bullukian, 69008 Lyon, France
16INRIA Grenoble-Rhône-Alpes, 655 Avenue de l’Europe, Montbonnot-Saint-Martin 38330, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattias Johansson
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mattias Johansson
Christopher I Amos
17Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher I Amos
Matthieu Foll
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthieu Foll
James D McKay
1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James D McKay
  • For correspondence: mckayj@iarc.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Germline genetic variants are involved in lung cancer (LC) susceptibility. Previous genome-wide association studies (GWAS) have implicated genes involved in smoking propensity and DNA repair but further work is required to identify additional LC susceptibility variants and to investigate LC disease development dynamics.

We have undertaken a family history-based genome-wide association (GWAx) study of LC, analysing 48,843 European cases with a parent/sibling with LC compared to 195,387 controls from the UK Biobank. This was meta-analysed with previously described LC GWAS results. We performed Polygenic Risk Scores (PRS) analyses and further evaluated the PRS influence on the somatic environment in exome (N=736) and genome sequencing (N=61) profiled cohorts.

Eight novel loci were identified including DNA repair genes (CHEK1, MDM4), metabolic genes (CYP1A1) and variants that were also associated with smoking propensity, such as both subunits of the neuronal α4β2 nicotinic acetylcholine receptor (CHRNA4 and CHRNB2). PRS analysis demonstrated that variants related to eQTLs and/or smoking propensity are enriched for susceptibility variants, including variants below genome-wide significant threshold. PRS of LC variants related to smoking propensity were associated with somatic mutation burden in two case cohorts, with individuals with higher polygenic genetic risk having increased numbers of somatic mutations in their lung tumours.

This study has expanded the number of susceptibility loci linked with LC and provided insights into the molecular mechanisms by which these susceptibility variants contribute to the development of lung cancer.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Institut National du Cancer (INCa) (GeniLuc 2017-1-TABAC-03-CIRC-1 - [TABAC 17 022], NIH/NCI, Integral NIH 5U19CA203654-03, Cancer Research UK [grant number C18281/A29019], the France Genomique National infrastructure, funded as part of the Investissements d'Avenir program managed by the Agence Nationale pour la Recherche (contract ANR-10-INBS-09). Christopher Amos is a Research Scholar of the Cancer Prevention Institute of Texas and supported by RR170048.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study contains a meta-analysis from already published data. The lung cancer cohort in McKay 2017 and the UK Biobank in Bycroft 2018. In the replication cohort for the somatic PRS, the GeniLuc cohort has not previously been publish. Ethnics for the GeniLuc cohort was reviewed by the IARC ethnics board (IARC IRB 12-05) and approved on 28th of April 2016.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The revisions have been made from feedback from the peer-review process. In short the whole manuscript has been re-edited to be more concise and reader friendly

Data Availability

Data is available on request - PRS panels and weights are within the supplementary data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden
Aurélie AG Gabriel, Joshua R Atkins, Ricardo CC Penha, Karl Smith-Byrne, Valerie Gaborieau, Catherine Voegele, Behnoush Abedi-Ardekani, Maja Milojevic, Robert Olaso, Vincent Meyer, Anne Boland, Jean François Deleuze, David Zaridze, Anush Mukeriya, Beata Swiatkowska, Vladimir Janout, Miriam Schejbalová, Dana Mates, Jelena Stojšić, Miodrag Ognjanovic, John S Witte, Sara R Rashkin, Linda Kachuri, Rayjean J Hung, Siddhartha Kar, Paul Brennan, Anne-Sophie Sertier, Anthony Ferrari, Alain Viari, Mattias Johansson, Christopher I Amos, Matthieu Foll, James D McKay
medRxiv 2021.04.26.21254132; doi: https://doi.org/10.1101/2021.04.26.21254132
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden
Aurélie AG Gabriel, Joshua R Atkins, Ricardo CC Penha, Karl Smith-Byrne, Valerie Gaborieau, Catherine Voegele, Behnoush Abedi-Ardekani, Maja Milojevic, Robert Olaso, Vincent Meyer, Anne Boland, Jean François Deleuze, David Zaridze, Anush Mukeriya, Beata Swiatkowska, Vladimir Janout, Miriam Schejbalová, Dana Mates, Jelena Stojšić, Miodrag Ognjanovic, John S Witte, Sara R Rashkin, Linda Kachuri, Rayjean J Hung, Siddhartha Kar, Paul Brennan, Anne-Sophie Sertier, Anthony Ferrari, Alain Viari, Mattias Johansson, Christopher I Amos, Matthieu Foll, James D McKay
medRxiv 2021.04.26.21254132; doi: https://doi.org/10.1101/2021.04.26.21254132

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10299)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1768)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)